Back to Results
First PageMeta Content
Amines / Quinazolines / Lung cancer / Tyrosine kinase receptors / Alkynes / Epidermal growth factor receptor / Cetuximab / Erlotinib / A431 cells / Medicine / Chemistry / Biology


Microsoft Word - Beca_JWFulbright_Informe definitivo_050617.doc
Add to Reading List

Document Date: 2009-06-30 03:37:46

Open Document

File Size: 511,89 KB

Share Result on Facebook

City

Santa Clara / /

Company

Affimetrix Inc. / EST01755 Chymotrypsinogen B1 Lipoprotein Lp / GM / /

Country

United States / /

IndustryTerm

dCHIP software / cell machinery / /

MedicalCondition

HuCCT1 tumors / several cancer / tumor / erlotinib treated tumors / cancer / tumors / squamous carcinoma / NSCLC / metastasis / cetuximab-treated tumors / vivo tumor / durable tumor / solid tumors / human cancer / resistant biliary tract cancer / sarcoma / A431 tumors / non-small cell lung cancer / glioma model / delayed tumor / head and neck cancer / Panc430 tumors / A549 lung cancer / biliary cancer / breast cancer / pancreatic cancer / Down syndrome / /

MedicalTreatment

anticancer therapy / surgery / /

Organization

Antonio Jimeno FINAL REPORT J.W. Fulbright Association / /

Person

Antonio Jimeno / Gene Hypothetical / Manuel Hidalgo / Antonio Jimeno Figure / Jimeno Figure / /

Position

Director of the Drug Development and Gastrointestinal Cancer Programs / /

Product

cisplatin / adenosine / /

ProgrammingLanguage

E / /

Technology

alpha / DNA Chip / antibodies / siRNA / hybridization / gene expression / DNA binding / Drug Development / apoptosis / avoid entering apoptosis / /

URL

www.dCHIP.org / /

SocialTag